FI70708C - Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar - Google Patents

Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar Download PDF

Info

Publication number
FI70708C
FI70708C FI790740A FI790740A FI70708C FI 70708 C FI70708 C FI 70708C FI 790740 A FI790740 A FI 790740A FI 790740 A FI790740 A FI 790740A FI 70708 C FI70708 C FI 70708C
Authority
FI
Finland
Prior art keywords
imidazolin
general formula
formula
pyridyl
compound
Prior art date
Application number
FI790740A
Other languages
English (en)
Finnish (fi)
Other versions
FI790740A (fi
FI70708B (fi
Inventor
Adrian Marxer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI790740A publication Critical patent/FI790740A/fi
Publication of FI70708B publication Critical patent/FI70708B/fi
Application granted granted Critical
Publication of FI70708C publication Critical patent/FI70708C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI790740A 1978-03-08 1979-03-05 Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar FI70708C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH251978 1978-03-08
CH251978 1978-03-08

Publications (3)

Publication Number Publication Date
FI790740A FI790740A (fi) 1979-09-09
FI70708B FI70708B (fi) 1986-06-26
FI70708C true FI70708C (fi) 1986-10-06

Family

ID=4235609

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790740A FI70708C (fi) 1978-03-08 1979-03-05 Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar

Country Status (28)

Country Link
US (2) US4292429A (ko)
EP (1) EP0004561B1 (ko)
JP (1) JPS54125668A (ko)
KR (2) KR820002098B1 (ko)
AR (2) AR225010A1 (ko)
AT (1) AT364375B (ko)
AU (1) AU531006B2 (ko)
CS (1) CS244656B2 (ko)
CY (1) CY1304A (ko)
DD (1) DD142336A5 (ko)
DE (1) DE2961198D1 (ko)
DK (1) DK95279A (ko)
ES (1) ES478342A1 (ko)
FI (1) FI70708C (ko)
GB (1) GB2016011B (ko)
GR (1) GR71998B (ko)
HK (1) HK80185A (ko)
HU (1) HU182940B (ko)
IL (1) IL56797A (ko)
MY (1) MY8700199A (ko)
NO (1) NO152606C (ko)
NZ (1) NZ189841A (ko)
OA (1) OA06201A (ko)
PH (1) PH16207A (ko)
PL (2) PL123150B1 (ko)
PT (1) PT69314A (ko)
SU (2) SU845779A3 (ko)
ZA (1) ZA791062B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338453A (en) 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
DE3213509A1 (de) * 1982-04-10 1983-10-20 Basf Ag, 6700 Ludwigshafen N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung
JPS6133173A (ja) * 1984-07-25 1986-02-17 Torii Yakuhin Kk アミジン化合物
JPS62501922A (ja) * 1984-12-12 1987-07-30 エム・ティー・ディー　メディカル　テクノロジー　アンド　ディベロプメント　リミテッド 病室等の装備方法
GB8906198D0 (en) * 1989-03-17 1989-05-04 Ciba Geigy Ag Compounds
CA2605784A1 (en) * 2005-05-03 2006-11-09 Pharma Mar, S.A. Antitumoral tetrahydro-pyrimidines
FR2901273B1 (fr) 2006-05-19 2010-12-24 Anaconda Pharma Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant
NZ592264A (en) 2008-09-17 2013-10-25 William Kingston Tideway anchor system
JP5761173B2 (ja) * 2010-03-04 2015-08-12 味の素株式会社 糖尿病又は肥満症の予防又は治療剤
BR112012021657B8 (pt) * 2010-03-04 2022-06-07 Ea Pharma Co Ltd Composto, agente farmacêutico, agente para conferir kokumi , e, tempero
CN102924380B (zh) * 2012-11-13 2014-12-31 齐鲁动物保健品有限公司 一种咪唑苯脲的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH234990A (de) * 1938-05-11 1944-10-31 Chem Ind Basel Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins.
GB813525A (en) * 1956-07-09 1959-05-21 Socony Mobil Oil Co Inc Fuel oil composition
GB1082964A (en) * 1963-06-25 1967-09-13 Wellcome Found New substituted imidazolines and their preparation and use
US3455940A (en) * 1965-12-07 1969-07-15 Herbert C Stecker Certain halo and dihalo n-substituted salicylamides
GB1174349A (en) * 1966-08-25 1969-12-17 Boehringer Sohn Ingelheim Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
US3846071A (en) * 1969-02-12 1974-11-05 Petrolite Corp Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts
NL7415845A (nl) * 1973-12-26 1975-06-30 Upjohn Co Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten.
US4088766A (en) * 1975-06-25 1978-05-09 The Upjohn Company Urea containing compositions and methods
US4233451A (en) * 1976-05-20 1980-11-11 The Procter & Gamble Company Process for making imidazolinium salts
US4353921A (en) * 1981-06-19 1982-10-12 Berlex Laboratories, Inc. Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use

Also Published As

Publication number Publication date
HK80185A (en) 1985-10-25
SU923367A3 (ru) 1982-04-23
OA06201A (fr) 1981-06-30
KR830000884B1 (ko) 1983-04-26
CS244656B2 (en) 1986-08-14
ATA171079A (de) 1981-03-15
NO152606C (no) 1985-10-23
FI790740A (fi) 1979-09-09
PT69314A (de) 1979-04-01
KR820002098B1 (ko) 1982-11-05
ES478342A1 (es) 1979-05-16
EP0004561B1 (de) 1981-11-04
US4292429A (en) 1981-09-29
AU4490079A (en) 1979-09-13
DD142336A5 (de) 1980-06-18
EP0004561A3 (en) 1979-11-14
DK95279A (da) 1979-09-09
NZ189841A (en) 1982-03-09
SU845779A3 (ru) 1981-07-07
PH16207A (en) 1983-08-05
JPS629109B2 (ko) 1987-02-26
AR225010A1 (es) 1982-02-15
DE2961198D1 (en) 1982-01-14
NO790765L (no) 1979-09-11
PL123150B1 (en) 1982-09-30
MY8700199A (en) 1987-12-31
AU531006B2 (en) 1983-08-04
EP0004561A2 (de) 1979-10-17
FI70708B (fi) 1986-06-26
AR227286A1 (es) 1982-10-15
NO152606B (no) 1985-07-15
US4420619A (en) 1983-12-13
GB2016011B (en) 1982-08-25
JPS54125668A (en) 1979-09-29
GB2016011A (en) 1979-09-19
GR71998B (ko) 1983-08-26
HU182940B (en) 1984-03-28
ZA791062B (en) 1980-03-26
CY1304A (en) 1985-12-06
IL56797A (en) 1982-09-30
PL116762B1 (en) 1981-06-30
AT364375B (de) 1981-10-12
PL213924A1 (ko) 1980-02-25

Similar Documents

Publication Publication Date Title
CA1190224A (en) Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists
FI70708C (fi) Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 2-imidazolin-1-yl-urinaemne- och -amidofoereningar
CS247073B2 (en) Production method of 2-substituted 4-amino-6,7-dimethoxyghinolins
US4166851A (en) Certain imidazo(1,2a)pyridine derivatives
HU207945B (en) Process for producing neuropeptide-y-antagonisticpharmaceutical compositions containing imidazolyl-alkyl-guanidine derivative
KR960010346B1 (ko) 4(3h)-퀴나졸리논 유도체, 이의 제조방법 및 약제학적 조성물
US3996245A (en) Spasmolytics
US5326879A (en) Indole derivatives
JPS62252780A (ja) 新規なインデノチアゾ−ル誘導体及びその製造法
JPS58128384A (ja) ベンゾジオキシン化合物、その製造方法、および精神作用障害治療用医薬組成物
US4125623A (en) Spasmolytics
US4233301A (en) Novel imidazoazines and imidazodiazines
US4221798A (en) Hypotensive 2-heterocycloamino-imidazolines
US3941804A (en) 1-Heteroarylsulphonyl-2-imino-imidazolidines
EP0264232A1 (en) 2-Azetidinone derivatives
HU188742B (en) Process for producing substituted 3,4-diamni-1,2,5-thiadiazoles and pharmaceutical compositions of hystamine-h2-receptor antagonistic aczivity containing them as active agents
CA1125759A (en) Process for the preparation of novel urea and amido compounds
US4330543A (en) Imidazoazines and imidazodiazines
US4389403A (en) 1-Aroyl-2-phenylamino-2-imidazolines, drugs containing these compounds, and use thereof
PL100615B1 (pl) Sposob wytwarzania nowych eterowych pochodnych oksymu
JPS5976083A (ja) ジヒドロピリジン類
IE47864B1 (en) Process for the preparation of novel urea and amido compounds
FI78107B (fi) Foerfarande foer framstaellning av antiulceroest tienoisotiazol-1,1-dioxidderivat.
KR840001284B1 (ko) 2-이미다졸린 유도체류의 제조방법
EP0008150B1 (en) 2,6-dichlorophenyl-substituted amino-imidazole derivatives, processes of preparing such derivatives and pharmaceutical preparations comprising said derivatives

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CIBA-GEIGY AG